Researchers, physician-scientists, trainees, and community members across Columbia gathered to explore the rapidly evolving field of cancer metabolism.
Adana Llanos, PhD, MPH, discusses the latest in breast cancer inequities following the American Cancer Society (ACS) biennial update of breast cancer statistics among women in the United States.
A new paper from Elham Azizi's lab and collaborators has been accepted in Genome Research, marking a significant advancement in the study of dynamic single-cell interactions.
Ricardo Cruz-Acuña, PhD' s hunger for research and learning began early. Now, with his own lab at the HICCC, he advocates for the new generation of underrepresented minority scientists.
Drs. Sankar Ghosh, Brent Stockwell, and Zhiguo Zhang are recipients of the translational research awards by the new partnership, Columbia-Sumitomo Dainippon Pharma Oncology Alliance.
Low- and middle-income countries are bearing the brunt of the global burden of cancer. To address this health gap, the HICCC has partnered with ICAP, ato launch the ICAP-HICCC Cancer Initiative.
A new analysis led by Andrea Califano, Dr, and Cory Abate-Shen, PhD, found that regardless of the cancer’s origin, tumors could be stratified in only 112 subtypes.
Congratulations to Drs. Juan Arriaga and Jessica Hawley for winning the 2020 PCF Young Investigator Award in support of their work in prostate cancer research.
Seven members of the Herbert Irving Comprehensive Cancer Center (HICCC) have been named as 2020 Highly Cited Researchers by Clarivate, landing them among the most influential researchers in the world.
In breast cancer, a building body of research has revealed multitude of cancer care disparities, and patients who are among the minority underserved demographic are hit the hardest.
Michael Shen, PhD, is a leading expert in prostate and bladder cancer research. His ongoing work with three-dimensional cultures--organoids--could contribute to the development of new therapies.